Hello everyone. I was in Texas for my quarterly CT and Bone Scans related to the clinical trial that I have been participating in since June 2021.
The CT reflected that my tumors are continuing to grow,albeit at a relatively slow pace (i.e millimeters versus centimeters) given my advanceds stage IV m CRPC.
The trial has defined protocols related fo tumor growth and I was advised that when I return to MD Anderson in January, if they grow at all, my time in the trial will conclude.
We discussed potential alternative treatments and chatted about Pluvicto. My MO stated that he had recently spoken directly with Novartis and they advised that they are experiencing significant supply chain issues resulting in a 6 to 9 month delay in availability.
Has anyone in the US either heard about this situation or if you were approved to receive the Pluvicto radioligand,had first hand experience with treatment availability?
I am trying to determine if this a viable option for me going forward or if I need to explore other clinical trial options.